On Friday, September 16, 2016, NCCN hosts a national policy summit on Biosimilars at the National Press Club in Washington.
After a presentation on Clinical Implications of of Biosimilars and Molecular Testing in Oncology by Sean Tunis, Center for Medical Technology Policy, I will be presenting on Regulatory Aspects of the same topics. The Summit runs from 8:30 to 3:00.
The full website is here.